MedTrace Logo

Conversation With Family Doctor to Increase COVID-19 Vaccine Uptake

NCT05207137 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 654

Last updated 2025-05-29

No results posted yet for this study

Summary

The investigators will randomise individuals from family doctors' lists of patients that are at risk of severe Coronavirus Disease 2019 (COVID-19), and that are not registered as having taken the vaccine against the disease. The patients will be randomised to receiving a phone call from their family physician where the participants are given the opportunity to raise questions they might have around vaccination. The investigators will assess whether this has an impact on vaccine uptake.

Conditions

Interventions

BEHAVIORAL

Telephone call about vaccination

Participants receive phone call from their family physician, where they are invited to ask questions about the COVID-19 vaccine.

Sponsors & Collaborators

  • Norwegian Institute of Public Health

    lead OTHER_GOV

Principal Investigators

  • Atle Fretheim, PhD · Norwegian Institute of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-03
Primary Completion
2022-04-28
Completion
2022-06-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05207137 on ClinicalTrials.gov